Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re‐staging TURBT and Intravesical Adjuvant Therapy
Abstract Objective This study aims to investigate the impact of risk group classification, restaging transurethral resection (re‐TURBT), and adjuvant treatment intensity on recurrence and progression risks in high‐grade Ta tumours in patients with non‐muscle invasive bladder cancer (NMIBC). Material...
Saved in:
| Main Authors: | Tarek Ajami, Sunwoo Han, Ruben Blachman‐Braun, Helen Y. Hougen, Yuval Avda, Mark L. Gonzalgo, Bruno Nahar, Sanoj Punnen, Dipen J. Parekh, Isildinha M. Reis, Chad R. Ritch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-08-01
|
| Series: | BJUI Compass |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/bco2.363 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rationale of restaging transurethral resection of bladder tumor in patients with nonmuscle invasive bladder cancer in the current era
by: Amit Sharma, et al.
Published: (2024-10-01) -
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
by: Dong Gyun Kim, et al.
Published: (2023-03-01) -
Recent Advances and Emerging Innovations in Transurethral Resection of Bladder Tumor (TURBT) for Non-Muscle Invasive Bladder Cancer: A Comprehensive Review of Current Literature
by: Ben Muvhar R, et al.
Published: (2025-03-01) -
Characterization of treatment patterns and outcomes in muscle-invasive bladder cancer patients in Sweden
by: Kelvin H.M. Kwok, et al.
Published: (2025-06-01) -
Double-J stenting during TURBT increases risk of metachronous upper tract urothelial carcinoma
by: Zhengfeng Wu, et al.
Published: (2025-06-01)